Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 July 2024 | Story Prof Danie Brand

The University of the Free State, through its Free State Centre for Human Rights, is pleased to present an online panel discussion titled, The Gaza crisis: How should South African universities engage with ‘pressing and urgent injustices’?   


Click to view document Join the Panel Discussion

Following the killing of 1 143 people and the taking of 247 hostages by Hamas during an armed incursion in Israel on 7 October 2023, Israel mounted an invasion of the Gaza Strip. In the ensuing bombardment and ground offensive – which is continuing ten months after the Hamas attack – Israel armed forces have killed more than 38 000 people. Hamas’ killing and continued holding of hostages and Israel’s sustained offensive – described as an ‘unfolding genocide’ and a ‘massacre’ – confront universities with an enduring question: how to engage as institutions ‘with pressing and urgent injustices’?


Join us for an online panel discussion where pertinent questions emerging from the current crisis will be discussed. Should a university such as the University of the Free State formulate an institutional response to the Gaza crisis? If so, what form should it take? Is a statement, as has already emanated from several other South African universities, appropriate and sufficient? How to deal with current ties with Israeli universities, businesses, and individual academics? Can the UFS remain silent?

Event details
Date: Monday 22 July 2024
Time: 15:00-17:00
Venue: Ms Teams
Click to view documentClick here to RSVP before 22 July 2024. 
A Microsoft Teams link will be shared for the online event.

For South African universities, the Gaza crisis is a particularly apt lens through which to consider this question. Firstly, because Israel’s invasion of Gaza also manifested as a ‘scholasticide’: a large-scale destruction of schools, universities, and other places of learning in Gaza and the killing of Palestinian teachers and academics. Secondly, because of the strong historical and current links between South Africa, Palestine, and Israel: Israel’s past collaboration with the South African apartheid regime; the South African liberation movement’s enduring relationship with Palestinian liberation; and the many uncomfortable congruences between South Africa’s history of racially determined injustice and the current ethno-/racial social, political, and geographical segregation in Israel/Palestine.

Moderator

Prof Francis Petersen: Vice-Chancellor and Principal, UFS. 

 

Speakers
Prof Kistner has held teaching positions in Comparative Literature at Wits University, Modern European Languages at Unisa, and Philosophy at the University of Pretoria and is an extraordinary professor in the University of the Free State Department of Public Law. She is currently working on intersections between political philosophy, social theory, jurisprudence, and psychoanalytic theory.

Prof Nieftagodien is the NRF South African Research Chair in Local Histories and Present Realities and is the Head of the History Workshop at the University of the Witwatersrand, where he also lectures in the Department of History. He is the co-author – with Phil Bonner – of books on the history of Alexandra, Ekurhuleni, and Kathorus, and has also published books on the history of Orlando West and the Soweto uprising, and co-edited a book on the history of the ANC.

Prof Gillespie is a political and legal anthropologist with a research focus on abolition in South Africa, particularly concerned with the ways in which criminal legal processes become vectors for the continuation of apartheid relations. She joined the Department of Anthropology/Sociology at the University of the Western Cape in 2018, prior to which she worked for a decade at the University of the Witwatersrand (Wits). In 2008, she co-founded the Johannesburg Workshop in Theory and Criticism (JWTC), an experimental project tasked with recrafting the work of critical theory beyond the Global North. She writes and teaches about urbanism, violence, sexualities, race, and the praxis of social justice. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept